封面
市场调查报告书
商品编码
1378467

阿米替林市场:按强度、按适应症、按配销通路、按地区

Amitriptyline Market, By Strength, By Indication, By Distribution Channel, By geography

出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2023年阿米替林的全球市场规模为6.07亿美元,预测期内(2023-2030年)年复合成长率为5.6%。

报告范围 报告详情
基准年 2022年 2023年市场规模 6.07 亿美元
过去的资料 2018-2021 预测期 2023-2030
预测期年复合成长率 5.60% 2030年市场规模预测 8.888 亿美元
图 1. 2023 年阿米替林全球市场占有率(%),依实力划分
阿米替林市场-IMG1

阿米替林是三环抗忧郁药物,具有镇静作用。阿米替林作用于某些在脑细胞之间传递资讯的化学信使(神经传导物质),有助于调节情绪。它适用于成人重度忧郁症、神经病变疼痛、慢性紧张型头痛 (CTTH) 和偏头痛的预防性治疗。它也用于治疗尿床。以锭剂形式提供。阿米替林透过增加大脑中的血清素水平来发挥作用。血清素是一种神经传导物质,是大脑释放到全身神经的化学物质。血清素被认为可以增强情绪、精神状态、睡眠和身体应对疼痛的能力。

市场驱动因素

忧郁症和躁郁症盛行率的增加预计将推动对阿米替林等三环抗忧郁药物的需求,并有助于全球阿米替林市场的成长

此外,主要市场参与者增加仿製药阿米替林等产品的推出预计将推动市场成长。此外,研究机构也正在进行临床试验,也促进了市场的成长。例如,2020年9月,加州大学评估了阿米替林对患有功能性GERD(食道(GERD))相关症状的成年患者的生理和行为机制,宣布启动临床试验。

本次测试的主要特点

  • 本报告对全球阿米替林市场进行了详细分析,并列出了以2022年为基准年的预测期(2023-2030)的市场规模和年复合成长率。
  • 它还揭示了各个细分市场的潜在商机,并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、业绩和策略等参数,介绍了全球阿米替林市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 本研究报告针对该产业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球阿米替林市场的各种策略矩阵,将促进相关人员的决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
  • 影响分析
  • 主要进展
  • 最近的产品发布/核准
  • 合併、收购和合作场景
  • 法规场景
  • PEST分析
  • 波特五力分析
  • 作用机制

第4章全球阿米替林市场 - COVID-19感染疾病的影响分析

  • 经济影响
  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 对医疗保健产业的影响

第5章阿米替林全球市场,依实力划分,2018-2030 年

  • 10毫克片剂
  • 25毫克片剂
  • 50毫克片剂
  • 75毫克片剂
  • 100毫克锭剂
  • 150毫克片剂

第6章全球阿米替林市场,依适应症划分,2018-2030 年

  • 沮丧
  • 遗尿症
  • 偏头痛
  • 慢性神经性疼痛
  • 其他的

第7章全球阿米替林市场,依配销通路划分,2018-2030

  • 医院药房
  • 零售药房
  • 网路药房

第8章全球阿米替林市场,按地区,2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • ASEAN
  • 韩国
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • Accord Healthcare Inc.
  • Viatris Inc.
  • Sandoz Inc.
  • Sun Pharmaceutical Industries Inc.
  • Vintage Pharmaceuticals Inc.
  • Zydus Pharmaceuticals USA Inc.
  • Watson laboratories Inc.
  • Torrent Pharmaceuticals Ltd.
  • Dr Reddy's Laboratories Ltd
  • Unichem Laboratories Ltd.
  • Apotex Inc.
  • Intas Pharmaceuticals Ltd

第10章章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI4226

Global amitriptyline market is estimated to be valued at US$ 607.0 Million in 2023 and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 607.0 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 5.60% 2030 Value Projection: US$ 888.8 Mn
Figure 1. Global Amitriptyline Market Share (%), By Strength, 2023
Amitriptyline Market - IMG1

Amitriptyline is a tricyclic antidepressant with sedative effects. Amitriptyline affects certain chemical messengers (neurotransmitters) that communicate between brain cells and help regulate the mood. The drug is indicated for treating major depressive disorder, neuropathic pain, the prophylactic treatment of chronic tension type headache (CTTH), and migraine in adults. It is also used in the treatment of nocturnal enuresis. It is available in tablet form. Amitriptyline functions by boosting serotonin levels in the brain. Serotonin is a neurotransmitter, a chemical that the brain releases to the nerves throughout the body. It is supposed to boost one's mood, mental condition, sleep, and how one's body handles pain. The rise in the prevalence of anxiety and depression across the world will act as a major driver for the expansion of the global amitriptyline market.

Market Dynamics

The increasing prevalence of depression or bipolar disorder is expected to drive demand for tricyclic antidepressants such as amitriptyline, thereby contributing to the growth of the global amitriptyline market. Moreover, an increase in the product launch, such as generic amitriptyline, by the key market players is expected to drive the market growth. In addition, research institutes are also engaged in conducting clinical trials which is contributing to the growth of the market. For instance, in September 2020, the University of California announced that it had initiated a clinical trial to assess the physiological and behavioral mechanisms associated with amitriptyline in adult patients with functional GERD (Gastroesophageal reflux disease (GERD)) related symptoms.

Key features of the study:

  • This report provides an in-depth analysis of the global amitriptyline market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global amitriptyline market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Accord Healthcare Inc., Viatris Inc., Sandoz Inc., Sun Pharmaceutical Industries Inc., Vintage Pharmaceuticals Inc., Zydus Pharmaceuticals USA Inc., Watson laboratories Inc., Torrent Pharmaceuticals Ltd., Dr Reddy's Laboratories Ltd., Unichem Laboratories Ltd., Apotex Inc. and Intas Pharmaceuticals Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global amitriptyline market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global amitriptyline market

Detailed Segmentation:

  • By Strength:
    • 10 mg tablets
    • 25 mg tablets
    • 50 mg tablets
    • 75 mg tablets
    • 100 mg tablets
    • 150 mg tablets
  • By Indication:
    • Depression
    • Nocturnal Enuresis
    • Migraine
    • Chronic Neuropathic Pain
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa
  • Company Profiles
    • Accord Healthcare Inc.
    • Viatris Inc.
    • Sandoz Inc.
    • Sun Pharmaceutical Industries Inc.
    • Vintage Pharmaceuticals Inc.
    • Zydus Pharmaceuticals USA Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Strength
    • Market Snapshot, By Indication
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Developments
  • Recent Product Launches/Approvals
  • Merger, Acquisition, Collaborations Scenario
  • Regulatory Scenario
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Mechanism of Action

4. Global Amitriptyline Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Heathcare Sector

5. Global Amitriptyline Market, By Strength, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • 10 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • 25 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • 50 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • 75 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • 100 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • 150 mg tablets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Amitriptyline Market, By Indication, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Depression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Nocturnal Enuresis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Migraine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Chronic Neuropathic Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Amitriptyline Market, By Distribution Channel, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Amitriptyline Market, By Region, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2019-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Min)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
  • China
  • Japan
  • India
  • Australia
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strength, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 - 2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Accord Healthcare Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Viatris Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sandoz Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sun Pharmaceutical Industries Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vintage Pharmaceuticals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zydus Pharmaceuticals USA Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Watson laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Torrent Pharmaceuticals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dr Reddy's Laboratories Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Unichem Laboratories Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Apotex Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Intas Pharmaceuticals Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About Us